USPTO serial 79404978
TOPADUR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 2, 2025
- Examiner
- PAQUIN, SAMUEL ROBERT
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with TOPADUR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Trina A. Longo
Trina A. Longo Schiffrin & Longo, P.C.8200 Greensboro DriveSuite 900McLean, VA 22102Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Non-medicated body care and beauty care cosmetics and preparations; non-medicated body care and beauty care cosmetics and preparations, namely, anti-aging skin care preparations, anti-aging creams, cream, oils, lotion, sprays, pencils and balms for cosmetic use, shampoo, aromatic and ethereal essences and oils, eye wash preparations not for medical use, eye compresses for cosmetic use, emulsions, gels and lotions for skin care, gels for cosmetic use, face creams for cosmetic use, face lotions for cosmetic use, hair balms being non-medicated, hair creams, hair gel, hair lotions, hair oil, hair care products not for medical use, hair care preparations, hair shampoo, hand lotions, creams for the skin, gels for the skin, lotions for the skin, skin care cosmetics, lotions for skin care, skin care preparations, preparations for improving the texture of the skin, body creams for cosmetic use, body oils, toiletries, body care and beauty care cosmetics, cosmetics and toiletries, cosmetics and cosmetic preparations, creams and gels for cosmetic use for face, body and hand care, lotions and creams for cosmetic use, creams and lotions for cosmetic use for face and body care, facial care preparations for cosmetic use, skin creams for cosmetic use, hair lotions for cosmetic use, skin lotions for cosmetic use, cosmetic preparations for skin care, body creams for cosmetic use, cosmetic preparations for skin renewal, cosmetic oils for the skin, cosmetic preparations, cosmetic preparations for body care, powders, creams and lotions for cosmetic use for the face, hand and body, lotions, creams and oils for cosmetic use for the body and skin for topical use, lotions, creams and preparations for care of the face, body, scalp and hair, products for face and body care, body and beauty care cosmetic preparations, cosmetics for the skin, non-medicated scalp treatment cream, non-medicated foot creams, non-medicated foot care preparations, non-medicated hair care preparations, skin creams and hair care preparations, non-medicated head care preparations, non-medicated body care preparations | ACTIVE | — |
| 005 | Pharmaceutical preparations for the prevention and treatment of infectious, inflammatory, oncological and chronic diseases, and for the prevention and treatment of chronic wounds in patients suffering from diabetes, for healing wounds in the case of burns and scar formation, for the prevention and treatment of eye diseases, aging phenomena and aging-related diseases, skin diseases, for promoting hair growth, for hearing disorders and cancer; medical and veterinary preparations for the prevention and treatment of infectious, inflammatory, oncological and chronic diseases, and for the prevention and treatment of chronic wounds in patients suffering from diabetes, for healing wounds in the case of burns and scar formation, for the prevention and treatment of eye diseases, aging phenomena and aging-related diseases, skin diseases, for promoting hair growth, for hearing disorders and cancer; chemico-pharmaceutical preparations for the prevention and treatment of infectious, inflammatory, oncological and chronic diseases, and for the prevention and treatment of chronic wounds in patients suffering from diabetes, for healing wounds in the case of burns and scar formation, for the prevention and treatment of eye diseases, aging phenomena and aging-related diseases, skin diseases, for promoting hair growth, for hearing disorders and cancer; chemical preparations for pharmaceutical use for the prevention and treatment of infectious, inflammatory, oncological and chronic diseases, and for the prevention and treatment of chronic wounds in patients suffering from diabetes, for healing wounds in the case of burns and scar formation, for the prevention and treatment of eye diseases, aging phenomena and aging-related diseases, skin diseases, for promoting hair growth, for hearing disorders and cancer; pharmaceutical drugs for the prevention and treatment of infectious, inflammatory, oncological and chronic diseases, and for the prevention and treatment of chronic wounds in patients suffering from diabetes, for healing wounds in the case of burns and scar formation, for the prevention and treatment of eye diseases, aging phenomena and aging-related diseases, skin diseases, for promoting hair growth, for hearing disorders and cancer; pharmaceutical preparations for the prevention and treatment of infectious, inflammatory, oncological and chronic diseases, and for the prevention and treatment of chronic wounds in patients suffering from diabetes, for healing wounds in the case of burns and scar formation, for the prevention and treatment of eye diseases, aging phenomena and aging-related diseases, skin diseases, for promoting hair growth, for hearing disorders and cancer for human beings; pharmaceutical, medical and veterinary preparations, chemico-pharmaceutical preparations for the prevention and treatment of infectious, inflammatory, oncological and chronic diseases, and for the prevention and treatment of chronic wounds in patients suffering from diabetes, for healing wounds in the case of burns and scar formation, for the prevention and treatment of eye diseases, aging phenomena and aging-related diseases, skin diseases, for promoting hair growth, for hearing disorders and cancer | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design services in the field of prevention and treatment of infectious, inflammatory, oncological and chronic diseases, and for the prevention and treatment of chronic wounds in patients suffering from diabetes, for healing wounds in the case of burns and scar formation, for the prevention and treatment of eye diseases, aging phenomena and aging-related diseases, skin diseases, for promoting hair growth, for hearing disorders and cancer; industrial analysis and industrial research services in the field of prevention and treatment of infectious, inflammatory, oncological and chronic diseases, and for the prevention and treatment of chronic wounds in patients suffering from diabetes, for healing wounds in the case of burns and scar formation, for the prevention and treatment of eye diseases, aging phenomena and aging-related diseases, skin diseases, for promoting hair growth, for hearing disorders and cancer; providing information and data relating to scientific and technological research and development; scientific and technological services as well as research services in the field of the development of pharmaceutical products, medical and veterinary preparations, chemico-pharmaceutical preparations, drugs for pharmaceutical use, in particular for the prevention and treatment of infectious, inflammatory, oncological and chronic diseases, and preferably for the prevention and treatment of chronic wounds in particular in patients suffering from diabetes, for healing wounds, in particular in case of burns and scar formation, for the prevention and treatment of eye diseases, aging phenomena and aging-related diseases, skin diseases, for promoting hair growth, for hearing disorders and cancer; scientific and technological services as well as research services in the field of the development of cosmetics and non-medicated body care and beauty care products; scientific and technological services as well as research services in the field of discovery development, development and formulation of medicines, product design and chemical synthesis, in particular for pharmaceutical products, medical and veterinary preparations, chemical-pharmaceutical preparations, drugs for pharmaceutical use, in particular for the prevention and treatment of infectious, inflammatory, oncological and chronic diseases, and preferably for the prevention and treatment of chronic wounds, in particular in patients suffering from diabetes, for healing wounds, in particular in case of burns and scar formation, for the prevention and treatment of eye diseases, aging phenomena and aging-related diseases, skin diseases, for promoting hair growth, for hearing disorders and cancer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Topadur Pharma AG
- Other trademarks owned by Topadur Pharma AG
- Other trademarks owned by Topadur Pharma AG
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named TOPADUR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 9, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 19, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 19, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 12, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 25, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 25, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 2, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 2, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 2, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 15, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 15, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 9, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 11, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 30, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 30, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 30, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 29, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 6, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 6, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 22, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 21, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 21, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 30, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 30, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 26, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |